Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked
- 1 November 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 295 (5), F1449-F1456
- https://doi.org/10.1152/ajprenal.00004.2008
Abstract
This study used 16 h/day measurement of renal blood flow (RBF) and arterial pressure (AP) to determine the role of nitric oxide (NO) in mediating the renal vasodilation caused by onset of type 1 diabetes. The AP and RBF power spectra were used to determine the autoregulatory efficiency of the renal vasculature. Rats were instrumented with artery and vein catheters and a Transonic flow probe on the left renal artery and were divided randomly into four groups: control (C), diabetes (D), control plus nitro-l-arginine methyl ester (l-NAME; CL), and diabetes plus l-NAME (DL). Mean AP averaged 90 ± 1 and 121 ± 1 mmHg in the D and DL groups, respectively, during the control period, and RBF averaged 5.9 ± 1.2 and 5.7 ± 0.7 ml/min, respectively. Respective C and CL groups were not different. Onset of diabetes (streptozotocin 40 mg/kg iv) in D rats increased RBF gradually, but it averaged 55% above control by day 14. In DL rats, on the other hand, RBF remained essentially constant, tracking with RBF in the nondiabetic C and CL groups for the 2-wk period. Diabetes did not change mean AP in any group. Transfer function analysis revealed impaired dynamic autoregulation of RBF overall, including the frequency range of tubuloglomerular feedback (TGF), and l-NAME completely prevented those changes as well. These data strongly support a role for NO in causing renal vasodilation in diabetes and suggest that an effect of NO to blunt RBF autoregulation may play an important role.Keywords
This publication has 58 references indexed in Scilit:
- Role of Glomerular Filtration Rate in Controlling Blood Pressure Early in DiabetesHypertension, 2008
- LACK OF BLOOD PRESSURE SALT‐SENSITIVITY SUPPORTS A PREGLOMERULAR SITE OF ACTION OF NITRIC OXIDE IN TYPE I DIABETIC RATSClinical and Experimental Pharmacology and Physiology, 2007
- Altered expression of genes regulating skeletal muscle mass in the portacaval anastamosis ratAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- Effects of calcium channel blockers on “dynamic” and “steady-state step” renal autoregulationAmerican Journal of Physiology-Renal Physiology, 2004
- Nitric Oxide May Prevent Hypertension Early in Diabetes by Counteracting Renal Actions of SuperoxideHypertension, 2004
- Interaction between nitric oxide and renal myogenic autoregulation in normotensive and hypertensive ratsCanadian Journal of Physiology and Pharmacology, 2001
- Macula densa derived nitric oxide in regulation of glomerular capillary pressureKidney International, 1996
- Long-term cardiovascular role of nitric oxide in conscious rats.Hypertension, 1994
- Cardiovascular responses to long-term blockade of nitric oxide synthesis.Hypertension, 1993
- COMPARISON OF THE CONSTANT INFUSION AND URINE COLLECTION TECHNIQUES FOR THE MEASUREMENT OF RENAL FUNCTION 1JCI Insight, 1948